Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.

Déchelotte B, Muñiz-Castrillo S, Joubert B, Vogrig A, Picard G, Rogemond V, Pinto AL, Lombard C, Desestret V, Fabien N, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2020 Mar 13;7(3). pii: e701. doi: 10.1212/NXI.0000000000000701. Print 2020 May.

2.

Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies.

Simard C, Vogrig A, Joubert B, Muñiz-Castrillo S, Picard G, Rogemond V, Ducray F, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2020 Mar 13;7(3). pii: e699. doi: 10.1212/NXI.0000000000000699. Print 2020 May.

3.

Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies.

Muñiz-Castrillo S, Ambati A, Dubois V, Vogrig A, Joubert B, Rogemond V, Picard G, Lin L, Fabien N, Mignot E, Honnorat J.

J Neurol. 2020 Mar 9. doi: 10.1007/s00415-020-09782-8. [Epub ahead of print]

PMID:
32152690
4.

Associations between HLA and autoimmune neurological diseases with autoantibodies.

Muñiz-Castrillo S, Vogrig A, Honnorat J.

Auto Immun Highlights. 2020 Jan 22;11(1):2. doi: 10.1186/s13317-019-0124-6. Review.

5.

Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features.

Vogrig A, Gigli GL, Nilo A, Pessa ME, Volpetti S, Pegolo E, Valente M.

J Neurovirol. 2019 Dec 5. doi: 10.1007/s13365-019-00821-3. [Epub ahead of print]

PMID:
31807988
6.

Epidemiology of paraneoplastic neurological syndromes: a population-based study.

Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, Valent F, Fabris M, Curcio F, Brigo F, Iacono D, Passadore P, Rana M, Honnorat J, Valente M.

J Neurol. 2020 Jan;267(1):26-35. doi: 10.1007/s00415-019-09544-1. Epub 2019 Sep 24.

PMID:
31552550
7.

Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature.

Vogrig A, Bernardini A, Gigli GL, Corazza E, Marini A, Segatti S, Fabris M, Honnorat J, Valente M.

Cerebellum. 2019 Oct;18(5):976-982. doi: 10.1007/s12311-019-01075-9. Review.

PMID:
31463826
8.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, Muñiz-Castrillo S, Roger M, Raimbourg J, Dayen C, Grignou L, Pallix-Guyot M, Lannoy J, Ducray F, Desestret V, Psimaras D, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 7;6(6). pii: e604. doi: 10.1212/NXI.0000000000000604. Print 2019 Nov.

9.

Seizure specificities in patients with antibody-mediated autoimmune encephalitis.

Vogrig A, Joubert B, André-Obadia N, Gigli GL, Rheims S, Honnorat J.

Epilepsia. 2019 Aug;60(8):1508-1525. doi: 10.1111/epi.16282. Epub 2019 Jul 8. Review.

PMID:
31283859
10.

Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis.

Smeralda CL, Gigli GL, Vogrig A, Marini A, Valente M.

J Neuroimmunol. 2019 May 15;330:55-58. doi: 10.1016/j.jneuroim.2019.01.006. Epub 2019 Feb 21.

PMID:
30825860
11.

Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis.

Vogrig A, Pauletto G, Lettieri C, Valente M, Gigli GL.

Neurol Sci. 2019 Jul;40(7):1503-1505. doi: 10.1007/s10072-019-3729-7. Epub 2019 Feb 7. No abstract available.

PMID:
30734134
12.

A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events.

Vogrig A, Hsiang JC, Ng J, Rolnick J, Cheng J, Parvizi J.

Epilepsy Behav. 2019 Jan;90:172-177. doi: 10.1016/j.yebeh.2018.11.030. Epub 2018 Dec 20.

PMID:
30580068
13.

Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.

Vogrig A, Joubert B, Maureille A, Thomas L, Bernard E, Streichenberger N, Cotton F, Ducray F, Honnorat J.

J Neurol. 2019 Feb;266(2):398-410. doi: 10.1007/s00415-018-9143-x. Epub 2018 Nov 29.

PMID:
30498914
14.

NRASQ61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called "forme fruste" of neurocutaneous melanosis.

Girolami I, Cima L, Ghimenton C, Zannoni M, Mombello A, Riva G, Cirielli V, Corradi G, Vogrig A, Di Stefano G, Novelli L, Gessi M, Eccher A.

Brain Tumor Pathol. 2018 Oct;35(4):217-223. doi: 10.1007/s10014-018-0328-x. Epub 2018 Aug 25.

PMID:
30145692
15.

Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case.

Brigo F, Vogrig A, Bratti A, Tavernelli V, Nardone R, Trinka E.

Epileptic Disord. 2018 Aug 1;20(4):301-312. doi: 10.1684/epd.2018.0983.

16.

Epidemiology of autoimmune versus infectious encephalitis.

Vogrig A, Brigo F, Valente M, Gigli GL.

Ann Neurol. 2018 May;83(5):1037. doi: 10.1002/ana.25229. Epub 2018 Apr 30. No abstract available.

PMID:
29637605
17.

Glioblastoma as differential diagnosis of autoimmune encephalitis.

Vogrig A, Joubert B, Ducray F, Thomas L, Izquierdo C, Decaestecker K, Martinaud O, Gerardin E, Grand S, Honnorat J.

J Neurol. 2018 Mar;265(3):669-677. doi: 10.1007/s00415-018-8767-1. Epub 2018 Jan 30.

PMID:
29383516
18.

Effect of thymectomy on refractory autoimmune status epilepticus.

Vogrig A, Pauletto G, Belgrado E, Pegolo E, Di Loreto C, Rogemond V, Honnorat J, Eleopra R.

J Neuroimmunol. 2018 Apr 15;317:90-94. doi: 10.1016/j.jneuroim.2018.01.009. Epub 2018 Jan 9.

PMID:
29336839
19.

Prognosis of status epilepticus in adults: recent advances and future directions.

Vogrig A, Pauletto G.

Eur J Neurol. 2017 Aug;24(8):e48. doi: 10.1111/ene.13342. No abstract available.

PMID:
28707814
20.

Nystagmus and Lower Extremity Hyperalgesia After Colectomy.

Vogrig A, Zanoni T, Moretto G.

JAMA. 2016 Oct 11;316(14):1488-1489. doi: 10.1001/jama.2016.13658. No abstract available.

PMID:
27727364
21.

Postencephalitic epilepsy in children and adults: Etiology matters.

Vogrig A.

Epilepsia. 2016 Apr;57(4):671-2. doi: 10.1111/epi.13317. No abstract available.

22.

Spinal arachnoid cyst as a cause of isolated, progressive, bilateral C5-C6 radiculopathy.

Vogrig A, Tonin P, Fabrizi GM, Fenzi F, Beltramello A, Sala F, Meglio M, Monaco S.

Spine J. 2016 Jun;16(6):e367-8. doi: 10.1016/j.spinee.2015.11.061. Epub 2015 Dec 8. No abstract available.

PMID:
26681354
23.

Bornavirus Associated with Fatal Human Encephalitis.

Vogrig A.

N Engl J Med. 2015 Nov 5;373(19):1880. doi: 10.1056/NEJMc1510342. No abstract available.

PMID:
26535521
24.

Web-based telemonitoring and delivery of caregiver support for patients with Parkinson disease after deep brain stimulation: protocol.

Marceglia S, Rossi E, Rosa M, Cogiamanian F, Rossi L, Bertolasi L, Vogrig A, Pinciroli F, Barbieri S, Priori A.

JMIR Res Protoc. 2015 Mar 6;4(1):e30. doi: 10.2196/resprot.4044.

25.

Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma.

Vogrig A, Ferrari S, Tinazzi M, Manganotti P, Vattemi G, Monaco S.

J Neurol Sci. 2015 Mar 15;350(1-2):105-6. doi: 10.1016/j.jns.2015.01.028. Epub 2015 Jan 29. No abstract available.

PMID:
25661887
26.

Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.

Vogrig A, Dorr L, Bouzidi N, Boucherle B, Wattiez AS, Cassier E, Vallon G, Ripoche I, Abrunhosa-Thomas I, Marin P, Nauton L, Thery V, Courteix C, Lian LY, Ducki S.

ACS Chem Biol. 2013 Oct 18;8(10):2209-16. doi: 10.1021/cb400308u. Epub 2013 Aug 23.

PMID:
23895101
27.

Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents.

Bouzidi N, Deokar H, Vogrig A, Boucherle B, Ripoche I, Abrunhosa-Thomas I, Dorr L, Wattiez AS, Lian LY, Marin P, Courteix C, Ducki S.

Bioorg Med Chem Lett. 2013 May 1;23(9):2624-7. doi: 10.1016/j.bmcl.2013.02.100. Epub 2013 Mar 14.

PMID:
23545111
28.

Access to 2,6-disubstituted piperidines: control of the diastereoselectivity, scope, and limitations. Applications to the stereoselective synthesis of (-)-solenopsine A and alkaloid (+)-241D.

Abrunhosa-Thomas I, Plas A, Vogrig A, Kandepedu N, Chalard P, Troin Y.

J Org Chem. 2013 Mar 15;78(6):2511-26. doi: 10.1021/jo302712f. Epub 2013 Feb 28.

PMID:
23397886
29.

Synthesis and evaluation of bidentate ligands designed to interact with PDZ domains.

Boucherle B, Vogrig A, Deokar H, Bouzidi N, Ripoche I, Thomas I, Marin P, Ducki S.

Bioorg Med Chem. 2011 Jul 15;19(14):4346-54. doi: 10.1016/j.bmc.2011.05.036. Epub 2011 May 24.

PMID:
21680189
30.

NMR evaluation of interactions between substituted-indole and PDZ1 domain of PSD-95.

Vogrig A, Boucherle B, Deokar H, Thomas I, Ripoche I, Lian LY, Ducki S.

Bioorg Med Chem Lett. 2011 Jun 1;21(11):3349-53. doi: 10.1016/j.bmcl.2011.04.011. Epub 2011 Apr 9.

PMID:
21530246

Supplemental Content

Loading ...
Support Center